← FDA DRUG APPROVALS

FDA ANDA · ANDA209877

PERAMPANEL

Sponsor: ACCORD HLTHCARE

APPLICATION
ANDA209877
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)

Products

PERAMPANELNone (Tentative Approval)
PERAMPANEL 10MG · TABLET · ORAL
PERAMPANELNone (Tentative Approval)
PERAMPANEL 6MG · TABLET · ORAL
PERAMPANELNone (Tentative Approval)
PERAMPANEL 2MG · TABLET · ORAL
PERAMPANELNone (Tentative Approval)
PERAMPANEL 12MG · TABLET · ORAL
PERAMPANELNone (Tentative Approval)
PERAMPANEL 8MG · TABLET · ORAL
PERAMPANELNone (Tentative Approval)
PERAMPANEL 4MG · TABLET · ORAL

Approval history

2021-06-08UNKNOWN · Original · standardTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →